Form 8-K - Current report:
SEC Accession No. 0001125345-21-000105
Filing Date
2021-09-16
Accepted
2021-09-16 16:05:50
Documents
14
Period of Report
2021-09-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mgnx-20210916.htm   iXBRL 8-K 35997
2 EX-99.1 esmomahoganypressrelease.htm EX-99.1 29084
3 EX-99.2 esmomgc018pressrelease.htm EX-99.2 20479
  Complete submission text file 0001125345-21-000105.txt   240286

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgnx-20210916.xsd EX-101.SCH 1899
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgnx-20210916_lab.xml EX-101.LAB 24833
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgnx-20210916_pre.xml EX-101.PRE 13041
7 EXTRACTED XBRL INSTANCE DOCUMENT mgnx-20210916_htm.xml XML 11137
Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36112 | Film No.: 211258009
SIC: 2834 Pharmaceutical Preparations